18 completed, 14 recruiting, 10 unknown, 5 active not recruiting. 31 Not applicable, 7 Phase 2, 3 Early Phase 1, 3 Phase 1, 1 Phase 3.
Follow Multiparametric Magnetic Resonance Imaging: new trials by email Literature Review of Multiparametric Magnetic Resonance Imaging trials Research Report on Multiparametric Magnetic Resonance Imaging
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer Biopsy Procedure, Biospecimen Collection, High-Dose Rate Brachytherapy - Prostate Adenocarcinoma, Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8 | Not applicable | Recruiting | Jonsson Comprehensive Cancer Center | 45 | 2026-05-11 | 2026-05-22 |
| Early Prediction of Neoadjuvant Chemotherapy Response in Bladder Cancer Using Quantitative Multiparametric MRI Multiparametric Magnetic Resonance Imaging (mpMRI) - MIBC, mpMRI | Recruiting | Assiut University | 39 | 2025-08-29 | 2025-10-02 | |
| Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer multiparametric magnetic resonance imaging (mpMRI) of the bladder, Transurethral resection of bladder tumour (TURBt), Circulating tumour DNA levels assessment - Bladder (Urothelial, Transitional Cell) Cancer, Bladder Cancer Requiring Cystectomy | Phase 3 | Recruiting | University of Rome Tor Vergata | 92 | 2025-08-15 | 2025-07-24 |
| Multiparametric MRI for Characterization of Hepatocellular Carcinoma Multiparametric MRI - Hepatocellular Carcinoma (HCC) | Recruiting | University Hospital Muenster | 128 | 2025-05-01 | 2025-07-02 | |
| An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique Flotufolastat F-18 Gallium, Magnetic Resonance Imaging, Multiparametric Magnetic Resonance Imaging - Prostate Carcinoma | Phase 2 | Recruiting | Emory University | 90 | 2025-04-18 | 2026-07-14 |
| Comparative Study of MRI and TU in Identifying Clinically Significant Prostate Cancer Among Ethnic Groups MRI (mpMRI) - Prostate Cancer | Active not recruiting | Superior University | 120 | 2025-03-17 | 2025-07-02 | |
| Performance of Lung MRI Combined to Synthetic CT in the Follow-up of Lung Nodules multiparametric MRI - Lung Cancer | Not applicable | Recruiting | University Hospital, Bordeaux | 50 | 2025-02-12 | 2026-07-09 |
| MRI and CT in Gastroesophageal Junction or Upper Gastric Adenocarcinoma mpMRI - Gastric Cancer, Gastroesophageal Junction Cancer | Active not recruiting | The First Affiliated Hospital with Nanjing Medical University | 100 | 2024-08-21 | 2024-10-15 | |
| Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial Apalutamide, Biospecimen Collection, Computed Tomography - Prostate Adenocarcinoma, Stage II Prostate Cancer AJCC v8 | Phase 2 | Recruiting | Jonsson Comprehensive Cancer Center | 95 | 2024-03-28 | 2026-07-17 |
| mpMRI Compared to Diagnostic TURBT in Patients With Suspected Muscle-Invasive Bladder Cancer mpMRI + Diagnostic TURBT - Urothelial Bladder Cancer, Muscle-Invasive Bladder Cancer | Not applicable | Recruiting | University of California, Irvine | 30 | 2024-03-27 | 2026-05-04 |
| 3D-ASL and TDD-MRI for True Progression and Pseudoprogression After Glioma Surgery Multiparametric MRI (3D-ASL and TDD-MRI) - Glioma, Brain Neoplasms | Active not recruiting | Lanzhou University Second Hospital | 75 | 2024-03-01 | 2026-07-07 | |
| Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer: a New Local Staging Paradigm mpMRI plus a same-day cystoscopic bladder biopsy, TURBT - Bladder Cancer, Muscle-invasive Bladder Cancer | Not applicable | Recruiting | Radboud University Medical Center | 360 | 2023-12-06 | 2026-01-08 |
| Prostate Resection After Microwave Ablation (PRAMA) Biospecimen Collection, Microwave Ablation, Multiparametric Magnetic Resonance Imaging - Prostate Carcinoma | Not applicable | Completed | University of Southern California | 1 | 2023-11-10 | 2025-11-28 |
| Tumor Heterogeneity of Renal Tumors Assessed by Multiparametric MRI With Direct Radiological-histopathological Correlation: an Explorative Study mpMRI - Kidney Cancers | Not applicable | Completed | University of Zurich | 9 | 2023-08-02 | 2026-07-20 |
| Assessment of Renal Function by Multiparametric MRI mpMRI - Renal Impairment | Early Phase 1 | Completed | University of Zurich | 46 | 2023-07-25 | 2025-12-09 |
| PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer Fluorine F 18 DCFPyL, Gadobenate Dimeglumine, Gadobutrol - Prostate Carcinoma | Phase 2 | Withdrawn | Northwestern University | 2023-06-17 | 2025-10-21 | |
| Multicentric Evaluation of the True Negative Predictive Value of Multiparametric MRI for the Detection of Prostate Cancer Using Cystoprostatectomy Specimen as Reference mpMRI - Prostate Cancer | Not applicable | Completed | Institut Paoli-Calmettes | 12 | 2023-06-13 | 2026-10-14 |
| rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance Biopsy of Prostate, Decipher Prostate Cancer Test, Flotufolastat F-18 Gallium - Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8 | Early Phase 1 | Recruiting | Northwestern University | 40 | 2023-06-07 | 2026-07-02 |
| Prostate Cancer Prevention Clinic for Men With Risk of Familial Prostate Cancer Panel sequencing, whole exome sequencing, whole genome sequencing - Prostate Cancer, Familial Prostate Cancer | Not applicable | Not yet recruiting | Heinrich-Heine University, Duesseldorf | 300 | 2023-02-01 | 2023-01-12 |
| Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer mpMRI - Prostate Cancer | Not applicable | Recruiting | National Cancer Institute (NCI) | 508 | 2022-11-18 | 2026-10-16 |
Showing 20 of 55. Sign in to see all of them.
Prostatic Neoplasms (35) · Urinary Bladder Neoplasms (5) · Brain Neoplasms (3) · Breast Neoplasms (2) · Cholangitis, Sclerosing (2) · Glioma (2) · Liver Cirrhosis, Biliary (2) · Liver Diseases (2) · Lung Neoplasms (2) · Neoplasms (2) · Carcinoma, Hepatocellular (1) · Carcinoma, Renal Cell (1) · Colonic Neoplasms (1) · Disease (1) · Disease Progression (1)
University of Southern California (4) · National Cancer Institute (NCI) (3) · Fondazione del Piemonte per l'Oncologia (2) · Heinrich-Heine University, Duesseldorf (2) · Jonsson Comprehensive Cancer Center (2) · Northwestern University (2) · Perspectum (2) · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (2) · University College, London (2) · University of Zurich (2) · Aarhus University Hospital (1) · Assiut University (1) · Cedars-Sinai Medical Center (1) · Chang Gung Memorial Hospital (1) · Dana-Farber Cancer Institute (1)
United States (21) · Italy (4) · United Kingdom (4) · China (3) · Egypt (3) · Netherlands (3) · Canada (2) · Denmark (2) · France (2) · Germany (2) · Switzerland (2) · Finland (1) · Pakistan (1) · Spain (1) · Taiwan (1)
Hossein Jadvar, MD (2) · Mark Emberton, MD, FRCS, MBBS (2) · Ahmed Mosbah (1) · Alan C Lee (1) · Amar Kishan (1) · Amr Darwish, Lecturer (1) · Andre Luis Abreu, MD (1) · Ashley E Ross (1) · Bodil G. Pedersen, MD, PhD (1) · Caroline Chung (1) · Christian Arsov, MD (1) · Clare Tempany-Afdhal (1) · Dagmar Wieczorek (1) · David A Woodrum, MD, PhD (1)
PMID 28110982, PMID 29147764, PMID 30040065, PMID 31000430, PMID 33023952, PMID 33893066, PMID 36127090, PMID 36351725, PMID 36511804, PMID 36520162, PMID 39427924, PMID 39694787, PMID 40177325, PMID 40540647, PMID 40819867, PMID 40906535, PMID 41833067, PMID 41985042, PMID 42089595, PMID 42308555
P30CA014089 (4), P30CA060553 (2), P30CA069533 (1), P30CA138292 (1), R01CA189295 (1), R01CA201709 (1), R21EB017568 (1), U01CA113913 (1), U10CA180820 (1)